CSBR - Champions Oncology Inc
Champions Oncology Inc Logo

CSBR - Champions Oncology Inc

https://www.championsoncology.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. The company is headquartered in Hackensack, New Jersey.

52W High
$11.99
52W Low
$3.60

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.51
Valuation
Fair
As of 2025-04-30 (Overview)
Trailing P/E (<15 better)
20.73
Forward P/E (<15 better)
22.88
EV/EBITDA (<8 favorable)
13.97
EV/Revenue (<3 favorable)
1.59
P/S (TTM) (<3 favorable)
1.66
P/B (<3 favorable)
25.00
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
26.18%
Institutions (25–75% balanced)
48.17%
Shares Outstanding
13,788,400
Float
5,196,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-04-30 (Overview)
Revenue (TTM)
56,944,000
Gross Profit (TTM)
28,555,000
EPS (TTM)
0.33
Profit Margin (>10% good)
0.08%
Operating Margin (TTM) (higher better)
-0.14%
ROE (TTM) (>15% strong)
0.50%
EPS YoY (Quarterly) (>10% good)
-0.29
Revenue YoY (Quarterly) (>8% good)
-0.12
Momentum
Bearish momentum
Value
-0.1031
Previous
-0.1256
Trend
Rising
Signal Cross
No cross

As of
Sep. 12, 2025